Bill Trombetta, PhD, professor, healthcare strategy, marketing, St. Joseph's University, discusses the breakout session at Trade & Channel Strategies in Philadelphia.
A session provides considerations for manufacturers during development, rollouts, and implementation, specifically as it pertains to the HSSP perspective.
Kevin O’Meara discusses Patient-Cetric 3.0 breakout session and the challenges of drug manufactures implementing Direct-to-Patient models.
A session investigates the drivers of these shortages and ways to mitigate them.
The seminar focuses on US supply chain resiliency, while remaining compliant and preserving patient access.
A case study explores a way to potentially transform commercial organizations, while driving revenue growth.
A panel uncovers how distribution channels are aligning commercialization efforts.
Conference keynote speech examines the industry’s critical developments of 2024 and offers a strategic outlook for next year.
The conference returns to Lyon, France and promises a timely and relevant agenda that attendees will resonate with.
Albert Thigpen, co-founder, Talentwise Consulting, shares how today’s consumer is empowered to make their own decisions as it relates to consumer choices in general, while outlining how the concept can be applicable to the healthcare and pharma industry.
Albert Thigpen, co-founder, Talentwise Consulting, explains how the specialty pharmacy sector has evolved over the years.
Albert Thigpen, co-founder, Talentwise Consulting, discusses the valuable buckets pertaining to the PBM space.
Albert Thigpen, co-founder, Talentwise Consulting, explains how to use these tactics in order to anticipate the future US healthcare policy environment.
Albert Thigpen, co-founder, Talentwise Consulting, offers highlights of the drug commercialization panel that he participated in.
Bill Roth, General Manager, Managing Partner, Blue Fin Group, discusses key takeaways of the breakout session.
A panel dives into the current and future outlook of healthcare policies.
Bill Roth, General Manager, Managing Partner, Blue Fin Group, discusses the key takeaways of this year's keynote speech.
Session dives into how healthcare policy implementation impacts stakeholders long-term.
William Sarraille, professor, University of Maryland Francis King Carey School of Law, discusses other standout sessions at this year’s Access Insights conference.
The session dives into the obstacles surrounding data usability, mandate compliance, initial adoption, and limitations in this arena.
William Sarraille, professor, University of Maryland Francis King Carey School of Law, discusses breakout session and the impact of healthcare policies on manufacturing and commercialization.
The conference’s opening keynote sets the scene for 2025 and the years to come.
Given the magnitude of LogiPharma USA for the pharma logistics industry, what were some of the biggest themes that came out of the conference?
Lucy Alexander, capabilities lead, global supply chain and strategy, AstraZeneca, discusses key takeaways from the breakout session at LogiPharma USA 2024.
The session details how these teachings span the entire pharma supply chain.
A panel offers its perspective on bolstering the temperature monitoring and data sharing process.
In an interview with Pharma Commerce Editor Nicholas Saraceno, Arnon Lopes, head, customer experience, pharma & healthcare, JAS, discusses ways that IoT can support sustainable supply chains at LogiPharma USA in Boston.
A panel offers insight surrounding the industry’s carbon footprint, including ways to begin initiating positive change.
Session discusses the soft skills needed to ensure that communication strategies are being followed with distributors and other logistical partners across the value chain.
In an interview with Pharma Commerce Editor Nicholas Saraceno, Mark Karhoff, supply chain & DSCSA consultant, National Association of Boards of Pharmacy, discusses the NABP's PULSE program and how it will support supply chains.
